MAY 14, 2018
Amanda Glassman, Liesl Schnabel and Rebecca Forman
Message from our Board Chair and President
Sebastian Bauhoff and Jonah Busch
Y-Ling Chi, Kalipso Chalkidou and Jesse Bump
Aid allocation has been a topic of much investigation across several fields. In particular, many studies have looked at the patterns of development assistance for health (DAH). For example, a study by Hanlon and colleagues found that regional variations in DAH country allocations were only in part explained by differences in disease burden or income levels. If DAH allocation is not primarily driven by the health and financial needs of those receiving it, then on what grounds is it allocated?
William Savedoff , Janeen Madan Keller and Julia Goldberg Raifman
Jeremy Konyndyk and Cindy Huang
In 1988, the World Health Organization (WHO) announced polio as the next eradication target. Since then the polio eradication effort has become one of the largest public-private partnerships successfully eliminating polio in all but three countries: Nigeria, Afghanistan, and Pakistan. Despite no reported cases in two years in Nigeria, on August 11, 2016, the WHO announced two new wild polio cases had been discovered in Northern Nigeria.
William Savedoff, Amanda Glassman, and Janeen Madan
Global health action has been remarkably successful at saving lives and preventing illness in many of the world’s poorest countries. This is a key reason that funding for global health initiatives has increased in the last twenty years. Nevertheless, financial support is periodically jeopardized when scandals erupt over allegations of corruption, sometimes halting health programs altogether.
Amanda Glassman Vice President for Programs and Director of Global Health Policy Center for Global Development
Along with my colleagues at the Center, I have been watching the Ebola epidemic unfold in West Africa and keeping a close eye on the world’s response. As you know, this outbreak was unprecedented in scale and impact. Liberia, Sierra Leone, and Guinea endured a total of more than 28,600 cases of the virus and 11,300 deaths. The disease took a heavy toll not only on families, but also on the health systems and economies of the afflicted countries.
As the Ebola epidemic in West Africa endures, some parallels are being drawn between the virus and HIV/AIDS. Both are spread by quite specific human behavior which is under conscious control: HIV by unprotected sex, Ebola by unsanitary burial practices, and both by contact with the bodily fluids of an infected person. However, with an incubation period of less than three weeks, Ebola progresses from infection to infectiousness more than 100 times as fast as untreated HIV. Thus, Ebola is like a pre-treatment HIV epidemic on steroids.
By Victoria Fan
More than two years after the disease broke out in October of 2010, cholera still festers in Haiti. The disease has killed nearly 8000 people and infected 6% of the Haitian population. There has been much blame and ill-will placed on the United Nations (UN) for its instigating role in this epidemic, and indeed the UN likely played a necessary (but not sufficient) role in the cholera outbreak in Haiti, which then spread to other parts of the Caribbean (see Recipe Box at bottom). But more concerning is their slow and small response to the epidemic in Haiti.
By Amanda Glassman in USAID, Vaccination
This is a joint post with Charles Kenny.
By Victoria Fan in Evaluation, Monitoring, and Measurement. This is a joint post with Amanda Glassman and Rachel Silverman.
In post-conflict Liberia, the National Health Plan set out a process for transitioning from emergency to sustainability under government leadership.
The Liberia Health Sector Pool Fund, which consists of DfID, Irish Aid, UNICEF, and UNHCR, was established to fund this plan and mitigate this transition by increasing institutional capacity, reducing the transaction costs associated with managing multiple donor projects, and fostering the leadership of the Liberian Health Ministry by allocating funds to national priorities.
This paper describes the major institutional weaknesses in global nutrition and presents two recommendations to address the joint problems of incoherence, lack of institutional leaders, and persistent underfunding. First, within the domain of global health-where a significant part of the programmatic response rests-current and potential funding agencies at the international level could create a shared set of principles that lay out expectations for the coordination, coherence, and collaboration among institutions that currently do or might receive funding for global nutrition programs.
Good planning and policymaking in the health
sector require timely, accurate information about spending on inputs and
services, as well as funding prospects in the near and medium terms. While
some routine data are available on total health expenditure (divided into
public and private spending) for most countries, more timely, complete,
and detailed data are required for policymaking.